SNOA

The bull case is real but thin: FY2026 revenue jumped 36.7% to $19.5M, the fastest growth in five years, led by U.S. sales +117% (OTC products and new distributors) and Europe +25%. The net loss narrowed for a fourth straight year to -$3.17M, and gross margin held steady at 38%. On P/S of 0.3 the stock looks statistically cheap. That is where the good news ends.

The balance sheet is the disqualifier. Operating cash flow was -$3.93M against just $2.40M of cash (down 55.4% YoY), so the company is burning more than it holds — a de facto going-concern setup that forces continual capital raises. It already has: shares outstanding exploded +191.3% in one year, which is why diluted EPS is still -$1.89 despite a smaller dollar loss. Stockholders' equity fell 29.8% to $3.10M while liabilities rose 17.1%, pushing liabilities/equity to 3.51x, and accumulated deficit sits at -$201M. ROE of -102.6% reflects a business that has never earned its cost of capital. Gross margin of 38% is too thin to self-fund the 12%-of-revenue R&D and 39%-of-revenue SG&A load, so operating margin remains negative at -12.6%.